Literature DB >> 19744827

The role of chemokines in the recruitment of lymphocytes to the liver.

Ye H Oo1, David H Adams.   

Abstract

Chemokines direct leukocyte trafficking and positioning within tissues. They thus play critical roles in regulating immune responses and inflammation. The chemokine system is complex involving interactions between multiple chemokines and their receptors that operate in combinatorial cascades with adhesion molecules. The involvement of multiple chemokines and chemokine receptors in these processes brings flexibility and specificity to recruitment. The hepatic vascular bed is a unique low flow environment through which leukocyte are recruited to the liver during homeostatic immune surveillance and in response to infection or injury. The rate of leukocyte recruitment and the nature of cells recruited through the sinusoids in response to inflammatory signals will shape the severity of disease. At one end of the spectrum fulminant liver failure results from a rapid recruitment of leukocytes that leads to hepatocyte destruction and liver failure at the other diseases such as chronic hepatitis C infection may progress over many years from hepatitis to fibrosis and cirrhosis. Chronic hepatitis is charactezised by a T lymphocyte rich infiltrate and the nature and outcome of hepatitis will depend on the T cell subsets recruited, their activation and function within the liver. Different subsets of effector T cells have been described based on their secretion of cytokines and specific functions. These include Th1 and Th2 cells and more recently Th17 and Th9 cells which are associated with different types of immune response and which express distinct patterns of chemokine receptors that promote their recruitment under particular conditions. The effector function of these cells is balanced by the recruitment of regulatory T cells that are able to suppress antigen-specific effectors to allow resolution of immune responses and restoration of immune homeostasis. Understanding the signals that are responsible for recruiting different lymphocyte subsets to the liver will elucidate disease pathogenesis and open up new therapeutic approaches to modulate recruitment in favour of resolution rather than injury. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744827     DOI: 10.1016/j.jaut.2009.07.011

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  48 in total

Review 1.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

2.  Chemokine antagonism in chronic hepatitis C virus infection.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.

Authors:  Ayako Suzuki; Elizabeth M Brunt; David E Kleiner; Rosa Miquel; Thomas C Smyrk; Raul J Andrade; M Isabel Lucena; Agustin Castiella; Keith Lindor; Einar Björnsson
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

4.  Novel challenges for the allergist.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

Review 5.  The autoimmune side of heart and lung diseases.

Authors:  Nancy Agmon-Levin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 6.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

Review 7.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

8.  Gut-liver axis and disease infidelity: a subject worth exploring.

Authors:  Prasenjit Das; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2014-10-03

9.  In vitro toxicity assessment of amphiphillic polymer-coated CdSe/ZnS quantum dots in two human liver cell models.

Authors:  Wesley E Smith; Jessica Brownell; Collin C White; Zahra Afsharinejad; Jesse Tsai; Xiaoge Hu; Stephen J Polyak; Xiaohu Gao; Terrance J Kavanagh; David L Eaton
Journal:  ACS Nano       Date:  2012-10-18       Impact factor: 15.881

10.  Management of patients with difficult autoimmune hepatitis.

Authors:  Richard Parker; Ye Htun Oo; David H Adams
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.